Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, June 17, 2021
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
[ Thu, Jun 17th 2021
] - WOPRAI
Wed, June 16, 2021
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
[ Wed, Jun 16th 2021
] - WOPRAI
Simon Baker Downgraded (BNTX) to Strong Sell on, Jun 16th, 2021
Simon Baker of Redburn Partners, Downgraded "BioNTech SE" (BNTX) to Strong Sell on, Jun 16th, 2021.
Simon has made no other calls on BNTX in the last 4 months.
There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, 3 agree with Simon's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Shibutani of "Goldman Sachs" Initiated at Hold and Held Target at $173 on, Tuesday, May 18th, 2021
- Daina Graybosch of "SVB Leerink" Maintained at Hold with Increased Target to $159 on, Tuesday, May 11th, 2021
- Olga Smolentseva of "Bryan Garnier" Downgraded from Strong Buy to Hold and Increased Target to $206 on, Tuesday, May 11th, 2021
This is the rating of the analyst that currently disagrees with Simon
- Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $240 on, Thursday, May 13th, 2021
